| scholarly article | Q13442814 |
| P2093 | author name string | Chander Raman | |
| Robert C Axtell | |||
| Scott R Barnum | |||
| Matthew S Webb | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 2928-2932 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice | |
| P478 | volume | 173 |
| Q37374073 | A Conserved Enhancer Element Differentially Regulates Developmental Expression of CD5 in B and T Cells |
| Q28295917 | A Ligand for CD5 Is CD5 |
| Q64882785 | A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation. |
| Q35428053 | Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients |
| Q36872742 | Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions |
| Q37983999 | Basic Science for the Clinician 54 |
| Q41377606 | CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204 |
| Q93147779 | CD5 on dendritic cells regulates CD4+ and CD8+ T cell activation and induction of immune responses |
| Q37017450 | CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells |
| Q37349079 | CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system |
| Q36218513 | CD5-dependent CK2 activation pathway regulates threshold for T cell anergy |
| Q42177117 | CD6 as a potential target for treating multiple sclerosis |
| Q34337963 | CD6 as a therapeutic target in autoimmune diseases: successes and challenges. |
| Q24670421 | CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76 |
| Q38994496 | Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex |
| Q37473165 | Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease |
| Q24618350 | Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis |
| Q42457039 | Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling |
| Q35815842 | Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination |
| Q37245952 | Lithium prevents and ameliorates experimental autoimmune encephalomyelitis |
| Q35658918 | Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans. |
| Q39534078 | Rescue of Tumor-Infiltrating Lymphocytes from Activation-Induced Cell Death Enhances the Antitumor CTL Response in CD5-Deficient Mice |
| Q55000833 | T Cell Calcium Signaling Regulation by the Co-Receptor CD5. |
| Q36643675 | T-cell modulatory properties of CD5 and its role in antitumor immune responses |
| Q37189412 | The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis |
| Q26853175 | The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis |
| Q37863856 | The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. |
| Q37483915 | Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses |
Search more.